Cero Therapeutics Holdings Total Assets Growth & History (CERO)
Cero Therapeutics Holdings's total assets was $3.6M for fiscal 2025.
View full Cero Therapeutics Holdings company overviewCero Therapeutics Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.6M | −$2.6M | −41.34% |
| 2024 | 2024-12-31 | $6.2M | $1.1M | +21.08% |
| 2023 | 2023-12-31 | $5.1M | −$37.2M | −87.90% |
| 2022 | 2022-12-31 | $42.4M | −$137.7M | −76.47% |
| 2021 | 2021-12-31 | $180.1M | — | — |
Cero Therapeutics Holdings quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.9M | −$4.3M | −69.37% |
| Q1 2026 | 2026-03-31 | $2.2M | −$5.8M | −72.41% |
| Q4 2025 | 2025-12-31 | $3.6M | −$2.6M | −41.34% |
| Q3 2025 | 2025-09-30 | $3.9M | −$2.6M | −39.75% |
| Q2 2025 | 2025-06-30 | $6.2M | −$1.2M | −15.85% |
| Q1 2025 | 2025-03-31 | $8.0M | −$1.1M | −11.72% |
| Q4 2024 | 2024-12-31 | $6.2M | $1.1M | +21.08% |
| Q3 2024 | 2024-09-30 | $6.5M | −$2.0M | −23.36% |
| Q2 2024 | 2024-06-30 | $7.4M | −$6.7M | −47.76% |
| Q1 2024 | 2024-03-31 | $9.1M | −$5.4M | −37.27% |
| Q4 2023 | 2023-12-31 | $5.1M | −$37.2M | −87.90% |
| Q3 2023 | 2023-09-30 | $8.5M | −$172.0M | −95.31% |
| Q2 2023 | 2023-06-30 | $14.1M | −$165.6M | −92.15% |
| Q1 2023 | 2023-03-31 | $14.4M | −$165.3M | −91.97% |
| Q4 2022 | 2022-12-31 | $42.4M | −$137.7M | −76.47% |
| Q3 2022 | 2022-09-30 | $180.5M | $180.2M | +59850.51% |
| Q2 2022 | 2022-06-30 | $179.7M | — | — |
| Q1 2022 | 2022-03-31 | $179.8M | — | — |
| Q4 2021 | 2021-12-31 | $180.1M | — | — |
| Q3 2021 | 2021-09-30 | $301,000 | — | — |
Cero Therapeutics Holdings total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Cero Therapeutics Holdings's total assets decreased from $180.1M to $3.6M, a change of −$176.4M. The latest reported quarter, Q2 2026, shows $1.9M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cero Therapeutics Holdings source filings ↗